OTC · Financial Statements

Kaya Holdings, Inc. (KAYS) Financial Statements

$0.00 OTC: KAYS Market Cap $12472

Kaya Holdings, Inc. most recently reported annual revenue of $0, net profit of $-2.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20202021202220232024
Revenue$1.0M$1.0M$1.0M$0$0
Operating Profit$-2.0M$-1.0M$-2.0M$-1.0M$-2.0M
Net Profit$-12.0M$10.0M$-4.0M$2.0M$-2.0M
EPS$-0.28$0.13$-0.04$0.01$-0.07
Op Margin-178.2%-160.7%-249.6%-633.7%-28343.2%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$2.0M$2.0M$1.0M$0$0
Total Liabilities$27.0M$16.0M$18.0M$16.0M$17.0M
Cash$0$1.0M$0$0$0
Borrowings$7.0M$8.0M$8.0M$8.0M$9.0M

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$0$-1.0M$-1.0M$-1.0M$-1.0M
Investing Cash Flow$0$3.0M$0$1.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$1.0M$-1.0M$0$0
Free Cash Flow$0$-1.0M$-1.0M$-1.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.05
FCF Yield-3685.56%
Quick Ratio0.04
Interest Coverage-0.64
Return 1Y-98.48%
Return 3Y-99.44%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
KAYS Overview KAYS Dividend Run Stock Screener